Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
47.71
+0.69 (1.47%)
Dec 20, 2024, 4:00 PM EST - Market closed
Apogee Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 2,715 | 1,342 | - |
| Enterprise Value | 1,973 | 919 | - |
| Last Close Price | 47.71 | 27.94 | - |
| PB Ratio | 3.70 | 3.53 | - |
| P/TBV Ratio | 4.53 | 3.53 | - |
| Debt / Equity Ratio | 0.02 | 0.01 | - |
| Quick Ratio | 16.28 | 19.24 | 15.22 |
| Current Ratio | 16.39 | 19.38 | 15.24 |
| Return on Equity (ROE) | -25.65% | -32.18% | - |
| Return on Assets (ROA) | -18.51% | -21.00% | - |
| Return on Capital (ROIC) | -19.27% | -22.18% | - |
| Earnings Yield | -5.40% | -6.26% | - |
| FCF Yield | -4.96% | -5.58% | - |
| Buyback Yield / Dilution | -272.26% | -915.57% | - |
| Total Shareholder Return | -272.26% | -915.57% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.